Kiora Pharmaceuticals Inc. (KPRX) is priced at $0.21 after the most recent trading session. At the very opening of the session, the stock price was $0.175 and reached a high price of $0.2199, prior to closing the session it reached the value of $0.17. The stock touched a low price of $0.1701.Recently in News on September 13, 2022, Kiora Pharmaceuticals Appoints Melissa Tosca as Executive Vice President of Finance. Salt Lake City, Utah–(Newsfile Corp. – September 13, 2022) – Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) (“Kiora” or the “Company”) has appointed Melissa Tosca as Executive Vice President of Finance. Mrs. Tosca will join the executive management team and oversee finance, SEC reporting and accounting functions as well as play a role in the company’s capital markets strategy and planning. You can read further details here
Kiora Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.4200 on 01/03/22, with the lowest value was $0.1215 for the same time period, recorded on 08/22/22.
Kiora Pharmaceuticals Inc. (KPRX) full year performance was -88.58%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Kiora Pharmaceuticals Inc. shares are logging -91.07% during the 52-week period from high price, and 72.02% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.12 and $2.34.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 12040874 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Kiora Pharmaceuticals Inc. (KPRX) recorded performance in the market was -86.16%, having the revenues showcasing -45.85% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 7.08M, as it employees total of 14 workers.
Kiora Pharmaceuticals Inc. (KPRX) in the eye of market guru’s
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.3011, with a change in the price was noted -0.32. In a similar fashion, Kiora Pharmaceuticals Inc. posted a movement of -60.57% for the period of last 100 days, recording 6,769,388 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for KPRX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Kiora Pharmaceuticals Inc. (KPRX): Stocks Technical analysis and Trends
Raw Stochastic average of Kiora Pharmaceuticals Inc. in the period of last 50 days is set at 31.36%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 32.46%. In the last 20 days, the company’s Stochastic %K was 30.13% and its Stochastic %D was recorded 39.75%.
If we look into the earlier routines of Kiora Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -86.16%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -70.77%, alongside a downfall of -88.58% for the period of the last 12 months. The shares increased approximately by -7.07% in the 7-day charts and went down by 54.13% in the period of the last 30 days. Common stock shares were lifted by -45.85% during last recorded quarter.